• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子在成体中的作用。

Roles for VEGF in the adult.

作者信息

Maharaj Arindel S R, D'Amore Patricia A

机构信息

Schepens Eye Research Institute, 20 Staniford St., Boston, MA 02114, USA.

出版信息

Microvasc Res. 2007 Sep-Nov;74(2-3):100-13. doi: 10.1016/j.mvr.2007.03.004. Epub 2007 Apr 6.

DOI:10.1016/j.mvr.2007.03.004
PMID:17532010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2128714/
Abstract

The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease preeclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies.

摘要

血管内皮生长因子(VEGF)在发育过程和病理学中的作用已广为人知,但其在正常成年组织中的功能却鲜为人知。在人类病理学中,针对VEGF使用抗血管生成疗法所带来的不良反应,已开始揭示VEGF在静止脉管系统中的潜在功能。来自VEGF及其受体在成体中的表达研究、子痫前期疾病以及实验性中和研究的进一步线索表明,VEGF参与内皮细胞存活和窗孔形成,以及非内皮细胞的信号传导和维持。VEGF的各种生化特性及其与其他生长因子的相互作用,可能是决定VEGF作为维持因子还是血管生成因子发挥作用的一个重要因素。深入了解VEGF在成体中的功能,可能会带来更有效的促血管生成和抗血管生成疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/5f619116ca4c/nihms34650f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/518cfe6b0bbb/nihms34650f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/0753c88a95ce/nihms34650f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/42730a4ee9f2/nihms34650f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/5f619116ca4c/nihms34650f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/518cfe6b0bbb/nihms34650f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/0753c88a95ce/nihms34650f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/42730a4ee9f2/nihms34650f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8990/2128714/5f619116ca4c/nihms34650f4.jpg

相似文献

1
Roles for VEGF in the adult.血管内皮生长因子在成体中的作用。
Microvasc Res. 2007 Sep-Nov;74(2-3):100-13. doi: 10.1016/j.mvr.2007.03.004. Epub 2007 Apr 6.
2
Therapeutic potential of manipulating VEGF splice isoforms in oncology.调控血管内皮生长因子剪接异构体在肿瘤学中的治疗潜力
Future Oncol. 2009 Jun;5(5):703-12. doi: 10.2217/fon.09.33.
3
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.发育和病理过程中的脑 angiogenesis:血管内皮生长因子的治疗方面。 (注:angiogenesis 常见释义为“血管生成” ,这里原词可能有误,推测是 angiogenesis)
FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31.
4
VEGF in biological control.生物控制中的血管内皮生长因子
J Cell Biochem. 2007 Dec 15;102(6):1358-67. doi: 10.1002/jcb.21579.
5
Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.癌症治疗中的血管生成抑制:血小板衍生生长因子(PDGF)和血管内皮生长因子(VEGF)及其受体:生物学功能及在恶性肿瘤中的作用
Recent Results Cancer Res. 2010;180:51-81. doi: 10.1007/978-3-540-78281-0_5.
6
Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.血管内皮生长因子和血管内皮生长因子受体抑制剂作为癌症治疗中的抗血管生成药物。
Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):59-71. doi: 10.2174/157489207779561426.
7
VEGF-targeted therapy: mechanisms of anti-tumour activity.血管内皮生长因子靶向治疗:抗肿瘤活性机制
Nat Rev Cancer. 2008 Aug;8(8):579-91. doi: 10.1038/nrc2403. Epub 2008 Jul 3.
8
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.血管内皮生长因子通路在肿瘤生长和血管生成中的作用。
J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7.
9
Targeting the vascular endothelial growth factor in hematologic malignancies.针对血液系统恶性肿瘤的血管内皮生长因子。
Eur J Haematol. 2012 Nov;89(5):373-84. doi: 10.1111/ejh.12009. Epub 2012 Sep 20.
10
Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling.丹酚酸 B 和阿魏酸通过调节 VEGF 信号通路协同促进 HUVECs 和斑马鱼的血管生成。
J Ethnopharmacol. 2022 Jan 30;283:114667. doi: 10.1016/j.jep.2021.114667. Epub 2021 Sep 29.

引用本文的文献

1
A modified technique for mechanical isolation of stromal vascular fraction yields increased final product volume and high viable nucleated cells count.一种用于机械分离基质血管成分的改良技术可增加最终产物体积并提高有活力的有核细胞计数。
J Exp Orthop. 2025 Jul 27;12(3):e70378. doi: 10.1002/jeo2.70378. eCollection 2025 Jul.
2
Testing retrogenesis and physiological explanations for tract-wise white matter aging: links to developmental order, fiber calibre, and vascularization.测试逆向发生及白质束老化的生理学解释:与发育顺序、纤维直径及血管形成的联系
Geroscience. 2025 Jul 15. doi: 10.1007/s11357-025-01773-9.
3
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.

本文引用的文献

1
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.血管内皮生长因子-A是视网膜神经元的一种存活因子,也是缺血性损伤适应性反应过程中的一种关键神经保护剂。
Am J Pathol. 2007 Jul;171(1):53-67. doi: 10.2353/ajpath.2007.061237.
2
Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model.过表达 VEGF 的人神经干细胞为小鼠卒中模型提供神经保护、血管生成和功能恢复。
PLoS One. 2007 Jan 17;2(1):e156. doi: 10.1371/journal.pone.0000156.
3
Sorafenib in advanced clear-cell renal-cell carcinoma.
超越血管:揭示血管内皮生长因子对神经元功能和结构的影响
J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8.
4
VEGFA, MYC, and JUN are abnormally elevated in the synovial tissue of patients with advanced osteoarthritis.在晚期骨关节炎患者的滑膜组织中,血管内皮生长因子A(VEGFA)、原癌基因Myc(MYC)和原癌基因Jun(JUN)异常升高。
Sci Rep. 2025 Jan 15;15(1):2066. doi: 10.1038/s41598-024-80551-7.
5
The improvement of fibrinogen, Ang-1, VEGF, BDNF in post-operative patients with brain trauma through target task-oriented phase training.通过目标导向性阶段训练改善脑外伤术后患者的纤维蛋白原、血管生成素-1、血管内皮生长因子、脑源性神经营养因子水平。
J Med Biochem. 2024 Jun 15;43(4):378-386. doi: 10.5937/jomb0-45490.
6
Characterization of Angiogenic, Matrix Remodeling, and Antimicrobial Factors in Preterm and Full-Term Human Umbilical Cords.早产和足月人脐带中血管生成、基质重塑和抗菌因子的特征分析
J Dev Biol. 2024 May 1;12(2):13. doi: 10.3390/jdb12020013.
7
Therapeutic Effects of Anti-Inflammatory and Anti-Oxidant Nutritional Supplementation in Retinal Ischemic Diseases.抗炎抗氧化营养补充在视网膜缺血性疾病中的治疗作用。
Int J Mol Sci. 2024 May 18;25(10):5503. doi: 10.3390/ijms25105503.
8
Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p/VEGFA and HuR/ZO-1 axes in esophageal squamous cell carcinoma.缺氧诱导的外泌体Circ-ZNF609通过miR-150-5p/VEGFA和HuR/ZO-1轴促进食管鳞状细胞癌的前转移微环境形成和癌症进展。
Cell Death Discov. 2024 Mar 12;10(1):133. doi: 10.1038/s41420-024-01905-8.
9
MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway.miR-210 通过激活 VEGF/Notch 信号通路改善去卵巢大鼠的绝经后骨质疏松症。
BMC Musculoskelet Disord. 2023 May 18;24(1):393. doi: 10.1186/s12891-023-06473-z.
10
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.基于可注射水凝胶的治疗性血管生成用于缺血性心脏病中的蛋白质递送
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.
索拉非尼治疗晚期透明细胞肾细胞癌
N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655.
4
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.舒尼替尼与干扰素α治疗转移性肾细胞癌的对比研究
N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044.
5
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.血管内皮生长因子过表达可延缓肌萎缩侧索硬化症小鼠的神经退行性变并延长其生存期。
J Neurosci. 2007 Jan 10;27(2):304-7. doi: 10.1523/JNEUROSCI.4433-06.2007.
6
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.单独使用紫杉醇-卡铂或联合贝伐单抗治疗非小细胞肺癌。
N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.
7
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.可溶性血管内皮生长因子受体-1有助于角膜抗血管生成屏障。
Br J Ophthalmol. 2007 Apr;91(4):505-8. doi: 10.1136/bjo.2006.107417. Epub 2006 Dec 6.
8
Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events.贝伐单抗治疗转移性结直肠癌:安全性及不良事件管理
Semin Oncol. 2006 Oct;33(5 Suppl 10):S26-34. doi: 10.1053/j.seminoncol.2006.08.001.
9
Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways.人血管内皮生长因子通过激活ERK-1/2和Akt信号通路在体内保护轴突切断的视网膜神经节细胞。
J Neurosci. 2006 Nov 29;26(48):12439-46. doi: 10.1523/JNEUROSCI.0434-06.2006.
10
Molecular mechanisms of VEGF-A action during tissue repair.组织修复过程中VEGF-A作用的分子机制。
J Investig Dermatol Symp Proc. 2006 Sep;11(1):79-86. doi: 10.1038/sj.jidsymp.5650016.